Loading
Yanuki
KEYWORD TOPIC
Evoke Pharma Secures Patent for GIMOTI, Extending Market Exclusivity | Evoke Pharma Secures Patent for GIMOTI, Extending Market Exclusivity

Business / Pharma

Evoke Pharma Secures Patent for GIMOTI, Extending Market Exclusivity

Evoke Pharma (NASDAQ: EVOK) has secured a patent for its GIMOTI® nasal spray, a treatment for gastroparesis. The U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance, extending market exclusivity to December 2036. This move...

Major Patent Win: GIMOTI Locks Down 6 More Years of Exclusivity for Revolutionary Gastroparesis Spray
Evoke Pharma Secures Patent for GIMOTI, Extending Market Exclusivity Image via Stock Titan
TOPIC evok stock